FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
227 letters match. Newest first.
-
DrugsNational Chemical Laboratories
National Chemical Laboratories’ OTC topical drugs were adulterated after FDA found manufacturing quality violations, including untested BZK and weak quality oversight.
High risk -
DrugsElemental Herbs Inc. d/b/a ALL good
Elemental Herbs (ALL good) cited for CGMP failures and unapproved, misbranded Goop Skin Recovery Balm.
High risk -
DrugsHygienic Labs, LLC
Hygienic Labs, an OTC drug manufacturer, failed to respond to FDA records requests.
Medium -
DrugsSeoul Cosmetics Co., Ltd.
FDA warned Seoul Cosmetics, a South Korean drug maker, over poor manufacturing quality and unapproved OTC drugs.
High risk -
DrugsZhao Qing Longda Biotechnology Co. Ltd.
FDA says Zhao Qing Longda Biotechnology refused records access for OTC drugs, including children’s toothpaste, and placed its drugs on import alert.
High risk -
DrugsGulf States International, Inc.
Gulf States International refused FDA requests for OTC drug manufacturing records, FDA says.
Medium -
DrugsMaison Blanche LLC
FDA warns Maison Blanche for refusing repeated requests for records on its OTC hand sanitizer.
Medium -
DrugsGreen Pharmaceutical Co. Ltd.
FDA warns South Korea's Green Pharmaceutical over OTC drug CGMP failures, including missing identity testing and weak quality unit.
High risk -
DrugsLex Inc.
FDA warns Lex Inc. of Medley, Florida, that its over-the-counter drugs are adulterated because manufacturing rules were not met, including missing toxic-ingredient testing.
High risk -
DrugsGadal Laboratories Inc.
FDA warned Gadal Laboratories of CGMP violations at its Miami drug plant, including unqualified suppliers and contamination risks in pediatric OTC drugs.
High risk -
DrugsMolluscumRx, Inc.
FDA told MolluscumRx, Inc. of Orlando, Florida that its molluscum lotion and soap are unapproved new drugs sold with unsupported cure claims.
High risk -
DrugsK. Boeun Pharmaceutical Co., Ltd.
K. Boeun Pharmaceutical's OTC drugs were cited for CGMP violations, including missing identity tests for DEG/EG-risk components and inadequate quality unit.
High risk -
DrugsInternational Laboratories Corp. Ltd.
International Laboratories Corp. Ltd. failed manufacturing-practice rules for OTC drugs, including component identity testing and quality-unit oversight.
High risk -
DrugsDenison Pharmaceuticals, LLC
Denison Pharmaceuticals was cited for manufacturing quality failures, contamination risks, and unapproved infant/homeopathic drugs.
High risk -
DrugsGTP International Corp
GTP International, a Mesquite, TX maker of OTC hand sanitizer, refused FDA's repeated requests for manufacturing records.
Medium -
DrugsFancystage Unipessoal, LDA
Portugal OTC drug maker Fancystage Unipessoal skipped identity testing of high-risk ingredients and lacked quality-unit control, FDA says.
High risk -
DrugsAvaria Health & Beauty Corp.
FDA cites Avaria Health & Beauty for manufacturing-rule violations in OTC drugs, including missing glycerin identity testing and weak quality unit.
High risk -
DrugsKM Pharmaceutical Co. Ltd.
FDA says KM Pharmaceutical refused to provide drug records and placed all its drugs on import alert.
High risk -
DrugsTan Alize Kozmetik Ve Temizlik Urunleri
FDA warns Turkish OTC drug maker Tan Alize over missing glycerin identity testing and a weak quality unit; import alert issued.
High risk -
DrugsSangleaf Pharm., Co. Ltd.
Sangleaf Pharm failed to give FDA requested records for OTC drugs, including children's toothpaste, at risk of DEG/EG contamination.
High risk -
DrugsLCC Ltd.
LCC Ltd., an OTC drug maker, lacked identity testing for risky ingredients and adequate quality oversight, FDA says.
High risk -
DrugsSuhan Aerosol
Suhan Aerosol, an Indian OTC drug maker, failed to test high-risk ingredients for toxic diethylene/ethylene glycol and lacked quality oversight.
High risk -
DrugsSkyline Herbals Private Limited
FDA warns India's Skyline Herbals after it ignored records requests for OTC drugs including toothpaste; all its drugs hit Import Alert 66-79.
High risk -
DrugsOrchid Lifesciences
FDA warns Orchid Lifesciences over over-the-counter drug testing gaps and weak quality unit.
High risk -
DrugsAvlon Industries, Inc.
FDA warned Avlon Industries that its over-the-counter drug manufacturing broke quality rules, citing missing identity tests for high-risk glycerin/propylene glycol and validation failures.
High risk -
DrugsZermat International S.A. de C.V.
FDA warns Zermat International about current good manufacturing practice violations for OTC drugs, including releasing out-of-specification lots without investigation.
High risk -
DrugsChemical Services Group, Inc./Royal Chemical Company
Royal Chemical Company made OTC hand sanitizer on equipment shared with industrial chemicals, and FDA found cleaning, supplier testing and quality unit failures.
High risk -
FoodAspire Pharmaceuticals, Inc.
FDA warning letter to Aspire Pharmaceuticals cites dietary supplement and drug CGMP violations, including falsified lab data and missing impurity testing.
High risk -
DrugsFrenda Corporation
FDA found Frenda made OTC alcohol and hand sanitizer under insanitary conditions with industrial chemical cross-contamination risk.
High risk -
DrugsProfounda, Inc.
FDA warns Profounda about manufacturing quality failures for over-the-counter drugs, including process validation, stability, water system, and glycerin testing.
High risk -
DrugsSkyless, LLC
FDA cited Skyless, LLC for CGMP failures and for selling three X-PASMO topical analgesic ointments as unapproved and misbranded drugs.
High risk -
DrugsDelta Kozmetik Sanayi Ve Ticaret-Selim Yesil
FDA warned Delta Kozmetik that its OTC drug products were adulterated due to CGMP violations.
High risk -
DrugsClean Cosmetics LLC
FDA warned Clean Cosmetics LLC over manufacturing failures in OTC hand sanitizer, including ethanol contaminated with methanol.
High risk -
DrugsMonkeypox-treatment.com
FDA warned Monkeypox-treatment.com and Eric Sminia for promoting Amazon-linked products as mpox treatments without FDA approval.
High risk -
DrugsFei Fah Medical Manufacturing Pte. Ltd.
FDA warned Fei Fah Medical Manufacturing over inadequate stability data, unvalidated test methods, and supplier testing failures for over-the-counter drugs.
High risk -
DrugsKobayashi Healthcare International, Inc.
Kobayashi's Georgia plant released Zim's OTC pain drugs without microbial testing and lacked quality unit oversight, FDA says.
High risk -
DrugsShuzy Rock Inc.
FDA warns Shuzy Rock Inc. of adulterated hand sanitizers made under insanitary conditions and found below labeled alcohol strength.
High risk -
DrugsThe Anthos Group, Inc.
Anthos Group refused FDA access to OTC drug records for VERTRA Hand Sanitizer, FDA says.
Medium -
DrugsEksa Mills S.A. de C.V.
FDA cited Eksa Mills for CGMP violations, including shared-equipment contamination risks, after an April 2022 inspection of its Mexican drug facility.
High risk -
DrugsSystem Kosmetik Produktionsgesellschaft fur kosmetische Gmbh
German OTC drug maker System Kosmetik was cited for manufacturing quality violations, including missing process and cleaning validation.
High risk -
DrugsVirgin Scent Inc. dba Artnaturals
FDA warns Artnaturals after hand sanitizer tests found benzene and acetaldehyde impurities and inspection found CGMP failures.
High risk -
DrugsEpisciences Inc.
FDA warns Episciences Inc. that its Boise, Idaho plant made OTC drugs without adequate batch testing, process validation and failure investigations.
High risk -
DrugsGordon Laboratories Inc.
FDA: Gordon Laboratories' artnaturals hand sanitizer held benzene and acetaldehyde impurities, and CGMP failures let them happen.
High risk -
DrugsVerde Cosmetic Labs LLC
FDA warned Verde Cosmetic Labs after an inspection found inadequate CGMP controls for OTC topical drugs, including cleaning and water system failures.
High risk -
DrugsJB Exchange Inc./Justified Laboratories
JB Exchange/Justified Laboratories sold unapproved skin tag and mole removal serums online, FDA says.
High risk -
DrugsAriella Naturals
FDA warned Ariella Naturals that its website sells unapproved mole and skin tag removal drugs without FDA approval.
High risk -
DrugsGuangzhou Orchard Aromatherapy & Skin Care Co., Ltd.
Guangzhou Orchard Aromatherapy & Skin Care refused FDA records requests for its over-the-counter hand sanitizers, leading to import alert.
High risk -
DrugsCustom Research Labs Inc.
FDA warned Custom Research Labs Inc. about manufacturing-practice violations and unapproved, misbranded OTC drugs, including hand sanitizers and topical analgesics.
High risk -
DrugsAire-Master of America, Inc.
FDA cites Aire-Master of America for CGMP failures and unapproved, misbranded hand sanitizers made at its Missouri plant.
High risk -
DrugsThe W.S. Badger Company, Inc.
FDA warned W.S. Badger over repeat manufacturing-quality failures in OTC drug products, including sunscreen process, cleaning, test-method, and OOS investigation problems.
High risk